Current Practices of Measuring and Reference Range Reporting of Free and Total Testosterone in the United States
- PMID: 26707506
- DOI: 10.1016/j.juro.2015.12.070
Current Practices of Measuring and Reference Range Reporting of Free and Total Testosterone in the United States
Abstract
Purpose: The evaluation and management of male hypogonadism should be based on symptoms and on serum testosterone levels. Diagnostically this relies on accurate testing and reference values. Our objective was to define the distribution of reference values and assays for free and total testosterone by clinical laboratories in the United States.
Materials and methods: Upper and lower reference values, assay methodology and source of published reference ranges were obtained from laboratories across the country. A standardized survey was reviewed with laboratory staff via telephone. Descriptive statistics were used to tabulate results.
Results: We surveyed a total of 120 laboratories in 47 states. Total testosterone was measured in house at 73% of laboratories. At the remaining laboratories studies were sent to larger centralized reference facilities. The mean ± SD lower reference value of total testosterone was 231 ± 46 ng/dl (range 160 to 300) and the mean upper limit was 850 ± 141 ng/dl (range 726 to 1,130). Only 9% of laboratories where in-house total testosterone testing was performed created a reference range unique to their region. Others validated the instrument recommended reference values in a small number of internal test samples. For free testosterone 82% of laboratories sent testing to larger centralized reference laboratories where equilibrium dialysis and/or liquid chromatography with mass spectrometry was done. The remaining laboratories used published algorithms to calculate serum free testosterone.
Conclusions: Reference ranges for testosterone assays vary significantly among laboratories. The ranges are predominantly defined by limited population studies of men with unknown medical and reproductive histories. These poorly defined and variable reference values, especially the lower limit, affect how clinicians determine treatment.
Keywords: hypogonadism; laboratories; reference values; testis; testosterone.
Copyright © 2016 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Comment in
-
Editorial Comment.J Urol. 2016 May;195(5):1561. doi: 10.1016/j.juro.2015.12.105. Epub 2016 Feb 5. J Urol. 2016. PMID: 26854992 No abstract available.
Similar articles
-
Wide variability in laboratory reference values for serum testosterone.J Sex Med. 2006 Nov;3(6):1085-1089. doi: 10.1111/j.1743-6109.2006.00334.x. J Sex Med. 2006. PMID: 17100942
-
Importance of total and measured free testosterone in diagnosis of male hypogonadism: immunoassay versus mass spectrometry in a population of healthy young/middle-aged blood donors.J Endocrinol Invest. 2021 Feb;44(2):321-326. doi: 10.1007/s40618-020-01304-7. Epub 2020 May 30. J Endocrinol Invest. 2021. PMID: 32474765
-
Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts.J Clin Endocrinol Metab. 2011 Aug;96(8):2430-9. doi: 10.1210/jc.2010-3012. Epub 2011 Jun 22. J Clin Endocrinol Metab. 2011. PMID: 21697255 Free PMC article.
-
Accurate Measurement and Harmonized Reference Ranges for Total and Free Testosterone Levels.Endocrinol Metab Clin North Am. 2022 Mar;51(1):63-75. doi: 10.1016/j.ecl.2021.11.002. Endocrinol Metab Clin North Am. 2022. PMID: 35216721 Review.
-
Testosterone Assays.Urol Clin North Am. 2022 Nov;49(4):665-677. doi: 10.1016/j.ucl.2022.07.009. Epub 2022 Oct 7. Urol Clin North Am. 2022. PMID: 36309422 Review.
Cited by
-
Association of total and free testosterone with cardiovascular disease in a nationally representative sample of white, black, and Mexican American men.Int J Impot Res. 2024 Jun;36(4):385-393. doi: 10.1038/s41443-022-00660-7. Epub 2022 Dec 29. Int J Impot Res. 2024. PMID: 36581758 Free PMC article.
-
Clinical utility of serum 17-hydroxyprogesterone as a marker for medical therapy for male infertility: recommendations based on clinical scenarios.Int J Impot Res. 2023 Mar;35(2):79-81. doi: 10.1038/s41443-022-00541-z. Epub 2022 Feb 23. Int J Impot Res. 2023. PMID: 35197555 Review.
-
Method for Simultaneous Determination of Free Concentration, Total Concentration, and Plasma Binding Capacity in Clinical Samples.J Pharm Sci. 2021 Mar;110(3):1401-1411. doi: 10.1016/j.xphs.2020.12.001. Epub 2020 Dec 8. J Pharm Sci. 2021. PMID: 33307041 Free PMC article.
-
Medical Diagnostic Tests: A Review of Test Anatomy, Phases, and Statistical Treatment of Data.Comput Math Methods Med. 2019 May 28;2019:1891569. doi: 10.1155/2019/1891569. eCollection 2019. Comput Math Methods Med. 2019. PMID: 31275427 Free PMC article. Review.
-
Free Testosterone Reflects Metabolic as well as Ovarian Disturbances in Subfertile Oligomenorrheic Women.Int J Endocrinol. 2018 Sep 10;2018:7956951. doi: 10.1155/2018/7956951. eCollection 2018. Int J Endocrinol. 2018. PMID: 30275830 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
